News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,621 Results
Type
Article (87609)
Company Profile (823)
Press Release (776172)
Multimedia
Podcasts (181)
Webinars (28)
Section
Business (233137)
Career Advice (4140)
Deals (39823)
Drug Delivery (141)
Drug Development (91307)
Employer Resources (203)
FDA (18310)
Job Trends (17411)
News (397564)
Policy (39934)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (151)
Alzheimer's disease (1703)
Antibody-drug conjugate (ADC) (280)
Approvals (18365)
Artificial intelligence (543)
Autoimmune disease (118)
Automation (31)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (174)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (542)
Cancer (4325)
Cardiovascular disease (383)
Career advice (3562)
Career pathing (38)
CAR-T (263)
CDC (57)
Cell therapy (727)
Cervical cancer (33)
Clinical research (76068)
Collaboration (1493)
Company closure (4)
Compensation (1000)
Complete response letters (64)
COVID-19 (2967)
CRISPR (92)
C-suite (660)
Cystic fibrosis (144)
Data (5265)
Decentralized trials (2)
Denatured (66)
Depression (123)
Diabetes (477)
Diagnostics (7127)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (253)
Drug pricing (198)
Drug shortages (36)
Duchenne muscular dystrophy (213)
Earnings (99795)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133869)
Executive appointments (1003)
FDA (20976)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1344)
Gene editing (192)
Generative AI (53)
Gene therapy (588)
GLP-1 (1055)
Government (5401)
Grass and pollen (8)
Guidances (376)
Healthcare (20941)
HIV (52)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (24)
Indications (62)
Infectious disease (3226)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (106)
Intellectual property (203)
Interviews (816)
IPO (17935)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (86)
Layoffs (650)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (14)
Lung cancer (612)
Lymphoma (300)
Machine learning (33)
Management (66)
Manufacturing (686)
MASH (161)
Medical device (14935)
Medtech (14969)
Mergers & acquisitions (22826)
Metabolic disorders (1242)
Multiple sclerosis (145)
NASH (23)
Neurodegenerative disease (248)
Neuropsychiatric disorders (76)
Neuroscience (2825)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (594)
Opinion (318)
Ovarian cancer (148)
Pain (175)
Pancreatic cancer (187)
Parkinson's disease (251)
Partnered (32)
Patents (440)
Patient recruitment (356)
Peanut (58)
People (66446)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23465)
Phase II (33016)
Phase III (24885)
Pipeline (3382)
Policy (310)
Postmarket research (3554)
Preclinical (10604)
Press Release (72)
Prostate cancer (212)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (728)
Real estate (7428)
Recruiting (80)
Regulatory (28256)
Reports (65)
Research institute (2704)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (79)
Schizophrenia (144)
Series A (221)
Series B (166)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (96)
The Weekly (113)
Vaccines (1075)
Venture capital (71)
Weight loss (415)
Women's health (67)
Worklife (21)
Date
Today (146)
Last 7 days (810)
Last 30 days (3951)
Last 365 days (33515)
2025 (30157)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1287)
Alabama (83)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (51141)
Australia (8994)
California (10328)
Canada (3021)
China (977)
Colorado (437)
Connecticut (465)
Delaware (298)
Europe (117627)
Florida (1504)
Georgia (334)
Hawaii (3)
Idaho (68)
Illinois (847)
India (57)
Indiana (499)
Iowa (20)
Japan (346)
Kansas (129)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1362)
Massachusetts (7689)
Michigan (329)
Minnesota (603)
Mississippi (6)
Missouri (129)
Montana (33)
Nebraska (26)
Nevada (111)
New Hampshire (81)
New Jersey (2834)
New Mexico (32)
New York (2761)
North Carolina (1484)
North Dakota (10)
Northern California (4807)
Ohio (315)
Oklahoma (22)
Oregon (51)
Pennsylvania (2119)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (54)
South Dakota (1)
Southern California (3954)
Tennessee (157)
Texas (1611)
United States (37705)
Utah (309)
Virginia (262)
Washington D.C. (85)
Washington State (868)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 864,621 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Nxera’s Quest for Profitability Claims 15% of Workforce
Nxera, which formerly went by Sosei, will also reprioritize its pipeline to focus on obesity, metabolic and endocrine diseases.
November 18, 2025
·
2 min read
·
Tristan Manalac
Stomach cancer
Jazz, Zymeworks Bispecific Achieves ‘Practice-Changing’ Results in Stomach Cancer Study
With positive data from the Phase III HERIZON-GEA-01 study, Zymeworks and Jazz Pharmaceuticals will file an approval application for Ziihera in the first half of 2026 for the treatment of gastroesophageal adenocarcinoma.
November 18, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Merck Continues Cuts With 204 Laid Off in New Jersey
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 18, 2025
·
86 min read
·
BioSpace Editorial Staff
Press Releases
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
November 18, 2025
·
5 min read
Press Releases
Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics
November 18, 2025
·
6 min read
Press Releases
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
November 18, 2025
·
5 min read
Press Releases
Apollomics Announces Changes to its Board of Directors and Composition of Committees
November 18, 2025
·
4 min read
Press Releases
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
November 18, 2025
·
8 min read
Press Releases
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
November 18, 2025
·
15 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s giredestrant becomes the first oral SERD to show superior invasive disease-free survival in early breast cancer
November 18, 2025
·
12 min read
1 of 86,463
Next
